Cargando…

Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanisms

Basophils play an important role in orienting Th2 immune response, and in the pathogenesis of allergic and inflammatory disorders. However, the mechanism by which basophils are kept in check remains unclear and hence we explored the role of regulatory T cells (Treg cells) in this process. We demonst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Mrinmoy, Stephen-Victor, Emmanuel, Bayry, Jagadeesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458635/ https://www.ncbi.nlm.nih.gov/pubmed/32923130 http://dx.doi.org/10.1080/2162402X.2020.1773193

Ejemplares similares

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
por: Bazhin, Alexandr V, et al.
Publicado: (2013)

Potential of regulatory T-cell-based therapies in the management of severe COVID-19
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2020)

Targeting the IL-12/IL-23 axis: An alternative approach to removing tumor induced immune suppression
por: Smyth, Mark J, et al.
Publicado: (2014)

Acid Stripping of Surface IgE Antibodies Bound to FcεRI Is Unsuitable for the Functional Assays That Require Long-Term Culture of Basophils and Entire Removal of Surface IgE
por: Galeotti, Caroline, et al.
Publicado: (2020)

T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment
por: Pedroza-Gonzalez, Alexander, et al.
Publicado: (2013)

Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients
por: Sharma, Meenu, et al.
Publicado: (2014)

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3
por: Concha-Benavente, Fernando, et al.
Publicado: (2013)

Bone marrow provides an environment that prevents suppression of therapeutic graft-vs.-tumor immunity by regulatory T cells
por: Guichelaar, Teun, et al.
Publicado: (2013)

Autoimmune and inflammatory diseases following COVID-19
por: Galeotti, Caroline, et al.
Publicado: (2020)

High risk of autoimmune diseases after COVID-19
por: Sharma, Chetan, et al.
Publicado: (2023)

Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
por: Garg, Abhishek D, et al.
Publicado: (2013)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

Involvement of STAT3 in immune evasion during lung tumorigenesis
por: Kida, Hiroshi, et al.
Publicado: (2013)

Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
por: Facciabene, Andrea, et al.
Publicado: (2012)

CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

IL-26: An Emerging Proinflammatory Member of the IL-10 Cytokine Family with Multifaceted Actions in Antiviral, Antimicrobial, and Autoimmune Responses
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2016)

The two faces of regulatory T cells in cancer
por: Blatner, Nichole R, et al.
Publicado: (2013)

IL-10 control of dendritic cells in the skin
por: Clausen, Björn E., et al.
Publicado: (2013)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

A haunted beast: Targeting STAT5B(N642H) in T-Cell Neoplasia
por: Pham, Ha Thi Thanh, et al.
Publicado: (2018)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

Expand to shield: IL-15 and in situ lymphocytic proliferation
por: Bindea, Gabriela, et al.
Publicado: (2021)

Impact of STAT1 and CD8(+) T cells on the antineoplastic activity of lapatinib and doxorubicin against spontaneous mammary tumors
por: Tymoszuk, Piotr, et al.
Publicado: (2013)

Toward understanding the genetics of regulatory T cells in ovarian cancer
por: DeRycke, Melissa S, et al.
Publicado: (2013)

Targeting the right regulatory T-cell population for tumor immunotherapy
por: Weiss, Vivian L., et al.
Publicado: (2012)

IL-21 in cancer immunotherapy: At the right place at the right time
por: Santegoets, Saskia JAM, et al.
Publicado: (2013)

Tumor suppression by stromal TIMPs
por: Shimoda, Masayuki, et al.
Publicado: (2016)

A new strategy to target regulatory T cells in solid tumors
por: Thomas-Schoemann, Audrey, et al.
Publicado: (2013)

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
por: Hansen, Wiebke
Publicado: (2013)

Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4(+) T Cell Responses
por: Saha, Chaitrali, et al.
Publicado: (2016)

Correction: Saha, C., et al. Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4(+) T Cell Responses. Molecules 2016, 21, 912
por: Saha, Chaitrali, et al.
Publicado: (2019)

IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012)

IL-17A is a central regulator of lung tumor growth
por: Reppert, Sarah, et al.
Publicado: (2012)

Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?
por: Swarbrick, Alexander, et al.
Publicado: (2013)

Targeted cancer immunotherapy: Mimicking physiological trans-presentation of IL-15
por: Müller, Dafne
Publicado: (2012)

The retinoblastoma protein: multitasking to suppress tumorigenesis
por: Vormer, Tinke L., et al.
Publicado: (2015)

IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2016)

‘Hardcore’ OX40(+) immunosuppressive regulatory T cells in hepatic cirrhosis and cancer
por: Piconese, Silvia, et al.
Publicado: (2014)

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients
por: Raja, Karthick Raja Muthu, et al.
Publicado: (2013)

Interleukin-2 treatment of tumor patients can expand regulatory T cells
por: Beyer, Marc
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cu6kcmpk68bmrc9e5peh64us38